LymphedemaV1, PubMed, Checkpoint, bibRecord, 007929

Erysipeloid rash: A rare adverse event induced by gemcitabine.

Identifieur interne : 007929 ( PubMed/Checkpoint ); précédent : 007928; suivant : 007930

Erysipeloid rash: A rare adverse event induced by gemcitabine.

Auteurs : Ana Ruiz-Casado [Espagne] ; David Gutiérrez ; Ignacio Juez

Source :

Journal of cancer research and therapeutics [ 1998-4138 ]

RBID : pubmed:26881588

Descripteurs français

KwdFr :
- Adulte, Adénocarcinome (anatomopathologie), Adénocarcinome (traitement médicamenteux), Désoxycytidine (analogues et dérivés), Désoxycytidine (effets indésirables), Exanthème (), Exanthème (anatomopathologie), Femelle, Humains, Maladies rares (), Maladies rares (anatomopathologie), Pronostic, Tumeurs du pancréas (anatomopathologie), Tumeurs du pancréas (traitement médicamenteux), Érysipéloïde (), Érysipéloïde (anatomopathologie).
MESH :
- analogues et dérivés : Désoxycytidine.
- anatomopathologie : Adénocarcinome, Exanthème, Maladies rares, Tumeurs du pancréas, Érysipéloïde.
- effets indésirables : Désoxycytidine.
- traitement médicamenteux : Adénocarcinome, Tumeurs du pancréas.
- Adulte, Exanthème, Femelle, Humains, Maladies rares, Pronostic, Érysipéloïde.

English descriptors

KwdEn :
- Adenocarcinoma (drug therapy), Adenocarcinoma (pathology), Adult, Deoxycytidine (adverse effects), Deoxycytidine (analogs & derivatives), Erysipeloid (chemically induced), Erysipeloid (pathology), Exanthema (chemically induced), Exanthema (pathology), Female, Humans, Pancreatic Neoplasms (drug therapy), Pancreatic Neoplasms (pathology), Prognosis, Rare Diseases (chemically induced), Rare Diseases (pathology).
MESH :
- chemical , adverse effects : Deoxycytidine.
- chemical , analogs & derivatives : Deoxycytidine.
- chemically induced : Erysipeloid, Exanthema, Rare Diseases.
- drug therapy : Adenocarcinoma, Pancreatic Neoplasms.
- pathology : Adenocarcinoma, Erysipeloid, Exanthema, Pancreatic Neoplasms, Rare Diseases.
- Adult, Female, Humans, Prognosis.

Abstract

Some rare cases of erysipelas-like or pseudocellulitis have been reported in relation to gemcitabine. This rare adverse event is more frequent in the presence of edema. Here, we report a case of pseudocellulitis after adjuvant treatment for pancreatic cancer. Oncologists should be aware of this infrequent and non-well understood adverse event. They should be especially careful when administering gemcitabine in the presence of lymphedema.

DOI: 10.4103/0973-1482.148711
PubMed: 26881588

Affiliations:

Espagne

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000999
to stream PubMed, to step Curation: 000999

Links to Exploration step

pubmed:26881588

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Erysipeloid rash: A rare adverse event induced by gemcitabine.</title>
<author><name sortKey="Ruiz Casado, Ana" sort="Ruiz Casado, Ana" uniqKey="Ruiz Casado A" first="Ana" last="Ruiz-Casado">Ana Ruiz-Casado</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Majadahonda</wicri:regionArea>
<wicri:noRegion>Majadahonda</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gutierrez, David" sort="Gutierrez, David" uniqKey="Gutierrez D" first="David" last="Gutiérrez">David Gutiérrez</name>
</author>
<author><name sortKey="Juez, Ignacio" sort="Juez, Ignacio" uniqKey="Juez I" first="Ignacio" last="Juez">Ignacio Juez</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:26881588</idno>
<idno type="pmid">26881588</idno>
<idno type="doi">10.4103/0973-1482.148711</idno>
<idno type="wicri:Area/PubMed/Corpus">000999</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000999</idno>
<idno type="wicri:Area/PubMed/Curation">000999</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000999</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000999</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000999</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Erysipeloid rash: A rare adverse event induced by gemcitabine.</title>
<author><name sortKey="Ruiz Casado, Ana" sort="Ruiz Casado, Ana" uniqKey="Ruiz Casado A" first="Ana" last="Ruiz-Casado">Ana Ruiz-Casado</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Majadahonda</wicri:regionArea>
<wicri:noRegion>Majadahonda</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gutierrez, David" sort="Gutierrez, David" uniqKey="Gutierrez D" first="David" last="Gutiérrez">David Gutiérrez</name>
</author>
<author><name sortKey="Juez, Ignacio" sort="Juez, Ignacio" uniqKey="Juez I" first="Ignacio" last="Juez">Ignacio Juez</name>
</author>
</analytic>
<series><title level="j">Journal of cancer research and therapeutics</title>
<idno type="eISSN">1998-4138</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (drug therapy)</term>
<term>Adenocarcinoma (pathology)</term>
<term>Adult</term>
<term>Deoxycytidine (adverse effects)</term>
<term>Deoxycytidine (analogs & derivatives)</term>
<term>Erysipeloid (chemically induced)</term>
<term>Erysipeloid (pathology)</term>
<term>Exanthema (chemically induced)</term>
<term>Exanthema (pathology)</term>
<term>Female</term>
<term>Humans</term>
<term>Pancreatic Neoplasms (drug therapy)</term>
<term>Pancreatic Neoplasms (pathology)</term>
<term>Prognosis</term>
<term>Rare Diseases (chemically induced)</term>
<term>Rare Diseases (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adénocarcinome (anatomopathologie)</term>
<term>Adénocarcinome (traitement médicamenteux)</term>
<term>Désoxycytidine (analogues et dérivés)</term>
<term>Désoxycytidine (effets indésirables)</term>
<term>Exanthème ()</term>
<term>Exanthème (anatomopathologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladies rares ()</term>
<term>Maladies rares (anatomopathologie)</term>
<term>Pronostic</term>
<term>Tumeurs du pancréas (anatomopathologie)</term>
<term>Tumeurs du pancréas (traitement médicamenteux)</term>
<term>Érysipéloïde ()</term>
<term>Érysipéloïde (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Deoxycytidine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Deoxycytidine</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Désoxycytidine</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term>
<term>Exanthème</term>
<term>Maladies rares</term>
<term>Tumeurs du pancréas</term>
<term>Érysipéloïde</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Erysipeloid</term>
<term>Exanthema</term>
<term>Rare Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Adenocarcinoma</term>
<term>Pancreatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Désoxycytidine</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term>
<term>Erysipeloid</term>
<term>Exanthema</term>
<term>Pancreatic Neoplasms</term>
<term>Rare Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Adénocarcinome</term>
<term>Tumeurs du pancréas</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Prognosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Exanthème</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladies rares</term>
<term>Pronostic</term>
<term>Érysipéloïde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Some rare cases of erysipelas-like or pseudocellulitis have been reported in relation to gemcitabine. This rare adverse event is more frequent in the presence of edema. Here, we report a case of pseudocellulitis after adjuvant treatment for pancreatic cancer. Oncologists should be aware of this infrequent and non-well understood adverse event. They should be especially careful when administering gemcitabine in the presence of lymphedema.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26881588</PMID>
<DateCreated><Year>2016</Year>
<Month>02</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>12</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1998-4138</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>11</Volume>
<Issue>4</Issue>
<PubDate><MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of cancer research and therapeutics</Title>
<ISOAbbreviation>J Cancer Res Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Erysipeloid rash: A rare adverse event induced by gemcitabine.</ArticleTitle>
<Pagination><MedlinePgn>1024</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0973-1482.148711</ELocationID>
<Abstract><AbstractText>Some rare cases of erysipelas-like or pseudocellulitis have been reported in relation to gemcitabine. This rare adverse event is more frequent in the presence of edema. Here, we report a case of pseudocellulitis after adjuvant treatment for pancreatic cancer. Oncologists should be aware of this infrequent and non-well understood adverse event. They should be especially careful when administering gemcitabine in the presence of lymphedema.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruiz-Casado</LastName>
<ForeName>Ana</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gutiérrez</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Juez</LastName>
<ForeName>Ignacio</ForeName>
<Initials>I</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>India</Country>
<MedlineTA>J Cancer Res Ther</MedlineTA>
<NlmUniqueID>101249598</NlmUniqueID>
<ISSNLinking>1998-4138</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0W860991D6</RegistryNumber>
<NameOfSubstance UI="D003841">Deoxycytidine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>B76N6SBZ8R</RegistryNumber>
<NameOfSubstance UI="C056507">gemcitabine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003841" MajorTopicYN="N">Deoxycytidine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004887" MajorTopicYN="N">Erysipeloid</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005076" MajorTopicYN="N">Exanthema</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D035583" MajorTopicYN="N">Rare Diseases</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>2</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26881588</ArticleId>
<ArticleId IdType="pii">JCanResTher_2015_11_4_1024_148711</ArticleId>
<ArticleId IdType="doi">10.4103/0973-1482.148711</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
</list>
<tree><noCountry><name sortKey="Gutierrez, David" sort="Gutierrez, David" uniqKey="Gutierrez D" first="David" last="Gutiérrez">David Gutiérrez</name>
<name sortKey="Juez, Ignacio" sort="Juez, Ignacio" uniqKey="Juez I" first="Ignacio" last="Juez">Ignacio Juez</name>
</noCountry>
<country name="Espagne"><noRegion><name sortKey="Ruiz Casado, Ana" sort="Ruiz Casado, Ana" uniqKey="Ruiz Casado A" first="Ana" last="Ruiz-Casado">Ana Ruiz-Casado</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007929 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 007929 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:26881588
   |texte=   Erysipeloid rash: A rare adverse event induced by gemcitabine.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:26881588" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Erysipeloid rash: A rare adverse event induced by gemcitabine.

Erysipeloid rash: A rare adverse event induced by gemcitabine.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki